Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer - An NRG/GOG study

CONCLUSIONS: Preoperative CA-125 was elevated in nearly 80% of high-risk early-stage ovarian cancer patients. Pre-chemotherapy CA-125 was associated with recurrence-free and overall survival; however, preoperative CA-125 was not prognostic.PMID:38134754 | DOI:10.1016/j.ygyno.2023.12.009

Source: Gynecologic Oncology - December 22, 2023 Category: Cancer & Oncology Authors: John K Chan Chunqiao Tian Joshua P Kesterson Ken Y Lin Kathleen Darcy Michael T Richardson Daniel S Kapp Bradley J Monk Leah McNally Lisa Landrum Larry Copeland Joan L Walker Robert M Wenham Neil Phippen Nick M Spirtos Krishnansu Tewari Mark Shahin Laurel Source Type: research